Kempema NelsonBRWehnerCLHallerIVRenierCM. Impact of pharmacist-led education on proper prophylactic enoxaparin dosing in obese patients. J Pharm Pract. 2023;14:8971900231193548. doi:10.1177/08971900231193548.
2.
SteinPDBeemathAOlsonRE. Obesity as a risk factor in venous thromboembolism. Am J Med. 2005;118(9):978-980. doi:10.1016/j.amjmed.2005.03.012.
3.
CheeABortzHYipJMcFadyenJD. Improving compliance with venous thromboembolism prophylaxis guidelines in obese inpatients. Intern Med J. 2022;52(9):1638-1642. doi:10.1111/imj.15899.
4.
KucukarslanSNPetersMMlynarekMNafzigerDA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163(17):2014-2018. doi:10.1001/archinte.163.17.2014.
